| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |